These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 15044958

  • 1. Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor.
    Guan M, Pang CP, Yam HF, Cheung KF, Liu WW, Lu Y.
    Cancer Gene Ther; 2004 May; 11(5):325-32. PubMed ID: 15044958
    [Abstract] [Full Text] [Related]

  • 2. Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth.
    Streck CJ, Zhang Y, Zhou J, Ng C, Nathwani AC, Davidoff AM.
    J Pediatr Surg; 2005 Jan; 40(1):236-43. PubMed ID: 15868591
    [Abstract] [Full Text] [Related]

  • 3. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo.
    Zhang T, Guan M, Xu C, Chen Y, Lu Y.
    Life Sci; 2007 Sep 29; 81(16):1256-63. PubMed ID: 17919663
    [Abstract] [Full Text] [Related]

  • 4. Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice.
    Hase R, Miyamoto M, Uehara H, Kadoya M, Ebihara Y, Murakami Y, Takahashi R, Mega S, Li L, Shichinohe T, Kawarada Y, Kondo S.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8737-44. PubMed ID: 16361561
    [Abstract] [Full Text] [Related]

  • 5. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
    Tsuchiya T, Nakahama K, Asakawa Y, Maemura T, Tanaka M, Takeda S, Morita M, Morita I.
    Gynecol Endocrinol; 2009 Feb 15; 25(2):104-9. PubMed ID: 19253105
    [Abstract] [Full Text] [Related]

  • 6. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
    Deryugina EI, Soroceanu L, Strongin AY.
    Cancer Res; 2002 Jan 15; 62(2):580-8. PubMed ID: 11809713
    [Abstract] [Full Text] [Related]

  • 7. Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells.
    Takenaka K, Yamagishi S, Jinnouchi Y, Nakamura K, Matsui T, Imaizumi T.
    Life Sci; 2005 Nov 04; 77(25):3231-41. PubMed ID: 15985268
    [Abstract] [Full Text] [Related]

  • 8. Down-regulation of PEDF expression by ribozyme transgene in endothelial and lung cancer cells and its impact on angiogenesis in vitro.
    Zhang L, Chen J, Ke Y, Mansel RE, Jiang WG.
    Oncol Rep; 2005 Dec 04; 14(6):1615-9. PubMed ID: 16273265
    [Abstract] [Full Text] [Related]

  • 9. Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis.
    Ek ET, Dass CR, Contreras KG, Choong PF.
    Cancer Gene Ther; 2007 Jul 04; 14(7):616-26. PubMed ID: 17479108
    [Abstract] [Full Text] [Related]

  • 10. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
    Zhang SX, Wang JJ, Gao G, Parke K, Ma JX.
    J Mol Endocrinol; 2006 Aug 04; 37(1):1-12. PubMed ID: 16901919
    [Abstract] [Full Text] [Related]

  • 11. PEDF inhibits growth and invasiveness of endometrial cancer cells in vitro.
    Guo T, Gu C, Li B.
    Panminerva Med; 2012 Dec 04; 54(4):299-304. PubMed ID: 23123582
    [Abstract] [Full Text] [Related]

  • 12. Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma.
    Matsumoto K, Ishikawa H, Nishimura D, Hamasaki K, Nakao K, Eguchi K.
    Hepatology; 2004 Jul 04; 40(1):252-9. PubMed ID: 15239109
    [Abstract] [Full Text] [Related]

  • 13. Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF.
    Ohno-Matsui K, Morita I, Tombran-Tink J, Mrazek D, Onodera M, Uetama T, Hayano M, Murota SI, Mochizuki M.
    J Cell Physiol; 2001 Dec 04; 189(3):323-33. PubMed ID: 11748590
    [Abstract] [Full Text] [Related]

  • 14. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
    Tao J, Tu YT, Huang CZ, Feng AP, Wu Q, Lian YJ, Zhang LX, Zhang XP, Shen GX.
    Br J Dermatol; 2005 Oct 04; 153(4):715-24. PubMed ID: 16181451
    [Abstract] [Full Text] [Related]

  • 15. [Pigment epithelium-derived factor gene therapy inhibits the growth of transplanted human hepatocellular carcinoma in nude mice].
    GAO Y, ZHANG W, ZHAO L, WANG XH.
    Zhonghua Gan Zang Bing Za Zhi; 2009 May 04; 17(5):363-7. PubMed ID: 19497203
    [Abstract] [Full Text] [Related]

  • 16. Effects of triamcinolone on the expression of VEGF and PEDF in human retinal pigment epithelial and human umbilical vein endothelial cells.
    Tong JP, Lam DS, Chan WM, Choy KW, Chan KP, Pang CP.
    Mol Vis; 2006 Dec 04; 12():1490-5. PubMed ID: 17167405
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor.
    Garcia M, Fernandez-Garcia NI, Rivas V, Carretero M, Escamez MJ, Gonzalez-Martin A, Medrano EE, Volpert O, Jorcano JL, Jimenez B, Larcher F, Del Rio M.
    Cancer Res; 2004 Aug 15; 64(16):5632-42. PubMed ID: 15313901
    [Abstract] [Full Text] [Related]

  • 18. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
    Laterra J, Nam M, Rosen E, Rao JS, Lamszus K, Goldberg ID, Johnston P.
    Lab Invest; 1997 Apr 15; 76(4):565-77. PubMed ID: 9111517
    [Abstract] [Full Text] [Related]

  • 19. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.
    Ishikawa H, Nakao K, Matsumoto K, Ichikawa T, Hamasaki K, Nakata K, Eguchi K.
    Hepatology; 2003 Mar 15; 37(3):696-704. PubMed ID: 12601367
    [Abstract] [Full Text] [Related]

  • 20. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
    Zhang L, Chen J, Ke Y, Mansel RE, Jiang WG.
    Int J Mol Med; 2006 May 15; 17(5):937-44. PubMed ID: 16596284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.